ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 528 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $76,934,000 | +0.8% | 2,200 | 0.0% | 0.10% | +19.5% |
| Q4 2017 | $76,340,000 | +2.4% | 2,200 | 0.0% | 0.08% | -9.9% |
| Q3 2017 | $74,536,000 | -20.8% | 2,200 | -20.3% | 0.09% | -18.0% |
| Q2 2017 | $94,088,000 | +9.5% | 2,760 | 0.0% | 0.11% | +13.3% |
| Q1 2017 | $85,946,000 | +27.9% | 2,760 | +12.2% | 0.10% | +32.4% |
| Q4 2016 | $67,207,000 | -13.3% | 2,460 | +4.2% | 0.07% | +27.6% |
| Q3 2016 | $77,549,000 | +18.9% | 2,360 | +9.3% | 0.06% | -34.1% |
| Q2 2016 | $65,210,000 | +12.4% | 2,160 | +4.9% | 0.09% | +18.9% |
| Q1 2016 | $58,009,000 | -56.8% | 2,060 | -47.9% | 0.07% | -53.5% |
| Q4 2015 | $134,238,000 | +61.1% | 3,954 | +51.0% | 0.16% | -7.6% |
| Q3 2015 | $83,337,000 | +27.0% | 2,619 | +154.3% | 0.17% | +173.0% |
| Q2 2015 | $65,621,000 | +15.5% | 1,030 | +24.1% | 0.06% | +14.5% |
| Q1 2015 | $56,796,000 | – | 830 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |